[Fundamental and clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology]. 1984

H Nakamura, and Y Iwata, and S Hayashi

The tissue penetration of sulbactam/cefoperazone (SBT/CPZ) was studied. The drug was also used in the treatment of 3 patients with gyneco-obstetrical infection. The results of these studies are summarized as follows. The elbow venous blood concentration and uterine arterial blood concentration were in about the same level and diminution curve of their concentrations took also a similar pattern. The tissue levels of the uterus and uterine appendices were determined and found to be high in the portio vaginalis, myometrium and oviduct. Each of the 3 patients with whom the dead space fluid concentration was determined showed her own concentration curve. SBT/CPZ was administered to 2 patients with adnexitis and 1 patient with pelvic peritonitis, and was markedly effective in 2 patients and moderately effective in other 1 patient.

UI MeSH Term Description Entries
D010397 Penicillanic Acid A building block of penicillin, devoid of significant antibacterial activity. (From Merck Index, 11th ed) Acid, Penicillanic
D010538 Peritonitis INFLAMMATION of the PERITONEUM lining the ABDOMINAL CAVITY as the result of infectious, autoimmune, or chemical processes. Primary peritonitis is due to infection of the PERITONEAL CAVITY via hematogenous or lymphatic spread and without intra-abdominal source. Secondary peritonitis arises from the ABDOMINAL CAVITY itself through RUPTURE or ABSCESS of intra-abdominal organs. Primary Peritonitis,Secondary Peritonitis,Peritonitis, Primary,Peritonitis, Secondary
D002438 Cefoperazone Semisynthetic broad-spectrum cephalosporin with a tetrazolyl moiety that is resistant to beta-lactamase. It may be used to treat Pseudomonas infections. Cefobid,Cefoperazon,Cefoperazone Sodium,Cefoperazone Sodium Salt,Céfobis,T-1551,T1551,Salt, Cefoperazone Sodium,Sodium Salt, Cefoperazone,Sodium, Cefoperazone,T 1551
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005122 Exudates and Transudates Exudates are fluids, CELLS, or other cellular substances that are slowly discharged from BLOOD VESSELS usually from inflamed tissues. Transudates are fluids that pass through a membrane or squeeze through tissue or into the EXTRACELLULAR SPACE of TISSUES. Transudates are thin and watery and contain few cells or PROTEINS. Transudates,Exudates,Transudates and Exudates,Exudate,Transudate
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000290 Adnexa Uteri Appendages of the UTERUS which include the FALLOPIAN TUBES, the OVARY, and the supporting ligaments of the uterus (BROAD LIGAMENT; ROUND LIGAMENT). Uterine Appendages,Appendage, Uterine,Appendages, Uterine,Uterine Appendage
D000292 Pelvic Inflammatory Disease A spectrum of inflammation involving the female upper genital tract and the supporting tissues. It is usually caused by an ascending infection of organisms from the endocervix. Infection may be confined to the uterus (ENDOMETRITIS), the FALLOPIAN TUBES; (SALPINGITIS); the ovaries (OOPHORITIS), the supporting ligaments (PARAMETRITIS), or may involve several of the above uterine appendages. Such inflammation can lead to functional impairment and infertility. Adnexitis,Inflammatory Disease, Pelvic,Inflammatory Pelvic Disease,Pelvic Disease, Inflammatory,Disease, Inflammatory Pelvic,Disease, Pelvic Inflammatory,Diseases, Inflammatory Pelvic,Diseases, Pelvic Inflammatory,Inflammatory Diseases, Pelvic,Inflammatory Pelvic Diseases,Pelvic Diseases, Inflammatory,Pelvic Inflammatory Diseases

Related Publications

H Nakamura, and Y Iwata, and S Hayashi
November 1984, The Japanese journal of antibiotics,
H Nakamura, and Y Iwata, and S Hayashi
October 1984, The Japanese journal of antibiotics,
H Nakamura, and Y Iwata, and S Hayashi
November 1984, The Japanese journal of antibiotics,
H Nakamura, and Y Iwata, and S Hayashi
November 1984, The Japanese journal of antibiotics,
H Nakamura, and Y Iwata, and S Hayashi
November 1984, The Japanese journal of antibiotics,
H Nakamura, and Y Iwata, and S Hayashi
November 1984, The Japanese journal of antibiotics,
H Nakamura, and Y Iwata, and S Hayashi
November 1984, The Japanese journal of antibiotics,
H Nakamura, and Y Iwata, and S Hayashi
December 1984, The Japanese journal of antibiotics,
H Nakamura, and Y Iwata, and S Hayashi
November 1984, The Japanese journal of antibiotics,
H Nakamura, and Y Iwata, and S Hayashi
November 1984, The Japanese journal of antibiotics,
Copied contents to your clipboard!